Alpha-glucosidase

Class

Alpha-glucosidase inhibitor

Alpha-glucosidase is a family of enzymes located on the brush border of cells lining the small intestine. Their normal role is to complete the final step of carbohydrate digestion, breaking down complex sugars and oligosaccharides derived from starch into simple, absorbable monosaccharides such as glucose. Inhibiting these enzymes slows this terminal breakdown step, so dietary carbohydrates are digested and absorbed more gradually along the length of the intestine rather than being converted to glucose quickly near the start of the small bowel. The biological rationale for this approach is to blunt the sharp rise in blood glucose that normally follows a carbohydrate-containing meal, a phenomenon known as postprandial hyperglycemia. This matters clinically in type 2 diabetes and related states of impaired glucose tolerance, where the body's ability to manage rapid glucose influxes is diminished. Because the mechanism acts locally within the gut lumen rather than altering insulin secretion or tissue sensitivity, it represents a distinct approach relative to agents that act on pancreatic or peripheral insulin pathways. Alpha-glucosidase inhibition is generally considered a modest, adjunctive strategy for glycemic control, most relevant to smoothing meal-related glucose excursions rather than addressing fasting glucose levels or underlying insulin resistance.